As acknowledged market leaders in Healthcare and Pharmaceuticals, our attorneys have an unmatched understanding of the regulatory regimes and market issues in one of the fastest growing industries in the world.
In a rapidly evolving environment, pharmaceutical companies face various challenges related to distributorship rights, intellectual property, compliance with governmental regulation, litigation, mergers and acquisitions, to capital raising and more. The Firm’s highly qualified pharmaceuticals experts help clients address these challenges and advise national players and multinationals on a full range of industry related issues, covering corporate and transactional needs, as well as dispute resolution.
Our deep and longstanding connections with our clients ensure that our lawyers bring genuine commercial knowledge of the sector to each challenge. The Firm's singular focus on understanding its clients' business, financial considerations, risk tolerance and long-term strategies, as well as the competitive and regulatory environments in which they operate, sets it apart.
Awards & Recognitions
The Firm is consistently recognized as a market leader by the prominent international legal directories Chambers & Partners, The Legal 500 and IFLR1000.
Band 1 Firm
Chambers Global 2022, Corporate & Finance
“Abou Jaoude & Associates maintains a commanding position at the forefront of the Lebanese legal market. The team […] has a strong track record of acting for big-name clients on a wide variety of cutting-edge matters.”
“A fine law firm with fine lawyers.”
Top Tier Firm
The Legal 500 EMEA 2022, Commercial, Corporate and M&A
“The team is known for its pharmaceutical sector work […].”
Top Tier Firm
IFLR1000 2022, Financial & Corporate
Lebanon Law Firm of the Year
Chambers Middle East Awards, 2021
Lebanon Law Firm of the Year
IFLR Middle East Awards, 2019
Band 1 Firm
Chambers Global 2021, 2020, 2019, 2018, 2017, 2016, 2015
Corporate & Finance
“Abou Jaoude & Associates impresses clients with the ‘360-degree coverage’ provided by its pool of experts […].”
“The firm is best known for its regional and international reach.”
Top Tier Firm
The Legal 500 EMEA 2021, 2020, 2019, 2018, 2017, 2016, 2015
Commercial, Corporate and M&A
“The ‘exceptional’ and ‘impressive’ team at Abou Jaoude & Associates Law Firm is noted for its ‘supportive’ service and its ‘extremely ethical conduct, which is of utmost professionalism’.”
Top Tier Firm
IFLR1000 2021, 2020, 2019, 2018, 2017, 2016, 2015
Financial & Corporate
“They always provide impeccable service.”
“The team is composed of experienced attorneys who are proactive, professional, reliable, and trustworthy.”
The Firm’s recent notable representative experience in Healthcare and Pharmaceuticals includes:
- Advised leading pharma group Benta on multi-million manufacturing and supply agreements (MSA) and distribution contracts with major international companies, including French multinational pharmaceutical company Sanofi, American multinational medical devices and healthcare company Abbott Laboratories, French global pharmaceutical company ROCHE, Irish global NYSE-listed pharmaceutical company Allergan, and German global medical technology company KLS Martin.
- Advised global leading pharma group Moderna on the regulatory framework governing the distribution of their novel Covid-19 vaccine in Lebanon, including advertising, registration, labeling and pharmacovigilance under complex healthcare sector regulations.
- Advised leading German healthcare company Fresenius SE, listed on the Dow Jones Sustainability Index (DJSI Europe), on a major distribution agreement with renowned Lebanese pharmaceutical company MacroMed for the import and distribution of dialysis medical products under complex healthcare sector regulations.
- Advised leading pharma company Pharmatrade (Malia group) on the first-of-its-kind import and distribution by the private sector of the Covid-19 vaccine SPUTNIK, involving highly complex regulatory licensing procedures and compliance with novel healthcare and data protection laws in Lebanon.
- Advised leading multi-industry Malia Group on a multi-million joint-venture with Saudi Arabia’s prominent hospital operator Al Rashid Group on the development of a major pharmaceutical plant in the King Abdallah Economic City.
- Advised global NGO Doctors Without Borders on complex contracts with hospitals in Lebanon under industry-specific regulations, and matters related to their engagement of doctors and nurses.
- Advised US tech healthcare company Epic on the transmission and use of health information about patients in the context of a major digitalization project with a premier Lebanese hospital, under complex regulations governing data privacy in the healthcare sector in Lebanon.
- Advised leading pharma group Benta on the US$30 Million joint-venture with a prominent pharma group in Egypt to build and operate a high capacity drug manufacture.
- Advised leading pharma group Benta on the US$60 Million cross-border acquisition of a pharmaceutical plant in France involving a highly complex government-supported reorganization plan and compliance with complex healthcare and labor regulations.
- Advised leading pharma group Benta on the multi-million strategic cross-border divestment of its equity stake in a major pharmaceutical plant in Egypt.
- Advised leading pharmaceutical group BENTA on 3 high-profile lawsuits in relation to distributorship agreements against French global pharmaceutical company ROCHE, Irish global NYSE-listed pharmaceutical company Allergan, and German global medical technology company KLS Martin.
- Advised leading pharmaceutical company Codipha on pre-litigation negotiations with the global leader in generic pharmaceuticals Sandoz in relation to the termination multi-million distributorship agreement.
- Advised a patient on a highly complex medical liability lawsuit against the renowned hospital American University of Beirut Medical Center (AUBMC).
- Advised a prominent doctor on a first-of-its-kind highly mediatized medical liability lawsuit.
